Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis

New England Journal of Medicine

Volumn 338, Issue 17, 1998, Pages 1186-1191

  Artlett, Carol M ^a   Smith, J Bruce ^a   Jimenez, Sergio A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BLOOD CELL; CONTROLLED STUDY; FEMALE; FETUS; FETUS CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY INFILTRATE; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; SYSTEMIC SCLEROSIS; Y CHROMOSOME;

ADOLESCENT; ADULT; AUTOIMMUNE DISEASES; BIOPSY; CASE-CONTROL STUDIES; DNA; FEMALE; FETUS; GRAFT VS HOST REACTION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; POLYMERASE CHAIN REACTION; REPRODUCTIVE HISTORY; SCLERODERMA, SYSTEMIC; SKIN; Y CHROMOSOME;

EID: 0032560034     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199804233381704     Document Type: Article

References (36)

1. Silman AJ, Black CM, Welsh KI. Epidemiology, demographics, genetics. In: Clements PJ, Furst DE, eds. Systemic sclerosis. Baltimore: Williams & Wilkins, 1996:23-49.
2. Medsger TA Jr. Epidemiology of systemic sclerosis. Clin Dermatol 1994;12:207-16.
3. Silman AJ, Jannini S, Symmons D, Bacon P. An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 1988;27:286-90.
4. Steen VD, Medsger TA Jr. Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am 1990;16:1-10.
5. Medsger TA Jr, Masi AT. Epidemiology of systemic sclerosis (scleroderma) Ann Intern Med 1971;74:714-21.
6. Chosidow O, Bagot M, Vernant J-P, et al. Sclerodermatous chrome graft-versus-host disease: analysis of seven cases. J Am Acad Dermatol 1992;26:49-55.
7. Valenta LJ, Elias JN. Familial scleroderma in a kindred with high incidence of autoimmune disease: correlation with HLA-A1/B8 haplotype. Arch Dermatol 1987;123:1438-40.
8. Clements PJ, Furst DE, Ho W, Gale R. Progressive systemic sclerosis-like disease following bone marrow transplantation. In: Black CM, Myers AR, eds. Current topics in rheumatology: systemic sclerosis (scleroderma). New York: Gower Medical Publishing, 1985:376-81.
9. Graham-Brown RAC, Sarkany I. Scleroderma-like changes due to chronic graft-versus-host disease. Clin Exp Dermatol 1983;8:531-8.
10. Lawley TJ Peck GL, Moutsopoulos HM, Gratwohl AA, Deisseroth AB Scleroderma, Sjogren-like syndrome, and chronic graft-versus-host disease. Ann Intern Med 1977;87:707-9.
11. Bos GMJ, Majoor GD, Slaaf DW, van der Gaar MJ, Weijmer-van Velzen JS van Breda Vriesman PJ. Similarity of scleroderma-like skin lesions in allogeneic and syngeneic bone marrow transplantation models. Transplant Proc 1989;21:3262-3.
12. Herzog P, Clements PJ, Roberts NK, Furst DE, Johnson CE, Feig SA. Progressive systemic sclerosis-like syndrome after bone marrow transplantation: clinical, immunologic, and pathologic findings. J Rheumatol 1980; 7:56-64.
13. Fleischmajer R, Perlish JS, Reeves JRT. Cellular infiltrates in scleroderma skin. Arthritis Rheum 1977;20:975-84.
14. Lambert IA, Suitters AJ, Janossy G, Thomas JA, Palmer S, Smith EG. Lymphoid infiltrates in skin in graft-versus-host disease. Lancet 1981;2: 1352.
15. Jimenez SA. Cellular immune dysfunction and the pathogenesis of scleroderma. Semin Arthritis Rheum 1983;13:Suppl 1:104-13.
16. Fagundus DM, Leroy EC. Cytokines and systemic sclerosis. Clin Dermatol 1994;12:407-17.
17. Kahaleh MB, LeRoy EC. Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration. Ann Intern Med 1989;110:446-50.
18. Postlethwaite AE. Connective tissue metabolism including cytokines in scleroderma. Curr Opin Rheumatol 1993;5:766-72.
19. Janin-Mercier A, Devergie A, van Cauwenberg D, et al. Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in man. Am J Pathol 1984;115:296-306.
20. Bell SA, Faust H, Mittermüller J, Kolb H-J, Meurer M. Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association. Br J Dermatol 1996;134:848-54.
21. O'Reilly RJ, Patterson JH, Bach FH, et al. Chimerism detected by HL-A typing. Transplantation 1973;15:505-7.
22. Bassukas ID. Is erythema toxicum neonatorum a mild self-limited acute cutaneous graft-versus-host-reaction from maternal-to-fetal lymphocyte transfer? Med Hypotheses 1992;38:334-8.
23. Schroder J. Transplacental passage of blood cells. J Med Genet 1975; 12:230-42.
24. Steele CD, Wapner RJ, Smith JB, Haynes MK, Jackson LG. Prenatal diagnosis using fetal cells isolated from maternal peripheral blood: a review. Clin Obstet Gynecol 1996;39:801-13.
25. Gill TJ III. Chimerism in humans. Transplant Proc 1977;9:1423-31.
26. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years post-partum. Proc Nad Acad Sci U S A 1996;93:705-8.
27. Silman AJ, Black C. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study. Ann Rheum Dis 1988;47:441-4.
28. Black CM, Stevens WM. Scleroderma. Rheum Dis Clin North Am 1989;15:193-212.
29. Nelson JL. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum 1996;39:191-4.
30. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure or extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16: 1215.
31. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
32. Patri S, Daheron L, Kitzis A, Chomel J-C. Evaluation of bone marrow transplantation efficiency by competitive PCR on Y sequences. PCR Methods Appl 1994;3:361-4.
33. Artlett CM, Welsh KI, Black CM, Jimenez SA. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics 1997;47:17-22.
34. Appleton AL, Curtis A, Wilkes A, Cant AJ. Differentiation of maternofetal GVHD from Omenn's syndrome in pre-BMT patients with severe combined immunodeficiency. Bone Marrow Transplant 1994;14:157-9.
35. Brubaker DB Immunopathogenic mechanisms of posttransfusion graft-vs-host disease. Proc Soc Exp Biol Med 1993;202:122-47.
36. Juji T, Takahashi K, Shibata Y, et al. Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan. N Engl J Med 1989;321:56.